The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Nuvo Pharmaceuticals Inc

TSX: NRI
Delayed quote

$3.78

Today's change-0.17 -4.30%
Updated July 25 3:22 PM EDT. Delayed by at least 15 minutes.
 

Nuvo Pharmaceuticals Inc

TSX: NRI
Delayed quote

$3.78

Today's change-0.17 -4.30%
Updated July 25 3:22 PM EDT. Delayed by at least 15 minutes.

Nuvo Pharmaceuticals Inc down $0.17

Nuvo Pharmaceuticals Inc closed sharply lower Tuesday, dropping $0.17 or 4.30% to $3.78. Over the last five days, shares have lost 6.67% and are down 33.10% for the last year to date. This security has underperformed the S&P TSX by 50.82% during the last year.

Key company metrics

  • Trailing P/E5.87×
  • P/E 1 year forward9.88×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$0.64
Updated July 25 3:22 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.49%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue7668
Total other revenue--------
Total revenue7668
Gross profit4335
Total cost of revenue3333
Total operating expense5446
Selling / general / administrative2112
Research & development0100
Depreciation / amortization0000
Interest expense (income), net operating----00
Unusual expense (income)--------
Other operating expenses, total--------
Operating income2212
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--000
Other--------
Income before tax2212
Income after tax2212
Income tax, total0000
Net income2212
Total adjustments to net income--------
Net income before extra. items2212
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2212
Inc. avail. to common incl. extra. items2212
Diluted net income2212
Dilution adjustment----00
Diluted weighted average shares12121212
Diluted EPS excluding extraordinary itemsvalue per share0.190.150.100.21
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.190.150.100.21